UK markets closed

AlzeCure Pharma AB (publ) (AC6.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
0.1300+0.0095 (+7.88%)
As of 09:15AM CEST. Market open.
Currency in EUR

Valuation measures4

Market cap (intra-day) 10.77M
Enterprise value 9.15M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)7.07
Enterprise value/revenue N/A
Enterprise value/EBITDA -0.25

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-66.62%
S&P500 52-week change 322.43%
52-week high 30.5220
52-week low 30.1145
50-day moving average 30.1821
200-day moving average 30.2640

Share statistics

Avg vol (3-month) 3321
Avg vol (10-day) 3200
Shares outstanding 570.06M
Implied shares outstanding 689.41M
Float 844.75M
% held by insiders 130.57%
% held by institutions 14.45%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in SEK.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-59.79%
Return on equity (ttm)-115.25%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -38.13M
Net income avi to common (ttm)-37.43M
Diluted EPS (ttm)-0.0500
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)19.04M
Total cash per share (mrq)0.31
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)2.57
Book value per share (mrq)N/A

Cash flow statement

Operating cash flow (ttm)-35.1M
Levered free cash flow (ttm)-21.79M